Clinical Director raises 'equity' issue as cancer drug is made available to VHI customers only

The Clinical Director of the National Centre for Pharma-economics has said that VHI's decision to make some cancer drugs available to some private customers raises an issue of equity.

Speaking on Today with Sean O'Rourke, Professor Michael Barry said that the drugs which have been given the go-ahead by VHI are currently "going through the process" of approval.